"Exercise Tolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.
| Descriptor ID |
D017079
|
| MeSH Number(s) |
G11.427.680.270
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Exercise Tolerance".
Below are MeSH descriptors whose meaning is more specific than "Exercise Tolerance".
This graph shows the total number of publications written about "Exercise Tolerance" by people in this website by year, and whether "Exercise Tolerance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 3 | 5 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 3 | 5 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2017 | 0 | 2 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 5 | 6 | 11 |
| 2021 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 2 | 4 |
| 2025 | 3 | 0 | 3 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Exercise Tolerance" by people in Profiles.
-
Sequential Bilateral Bronchoscopic Lung Volume Reduction for Residual Hyperinflation Following Successful Index Procedure in Pulmonary Emphysema: A Multicenter Study. J Bronchology Interv Pulmonol. 2026 Apr 01; 33(2).
-
Long-Term Pulmonary Rehabilitation Enhances Cerebral Oxygenation, Functional Capacity, and Psychological Health in Idiopathic Pulmonary Fibrosis. Med Sci Sports Exerc. 2026 04 01; 58(4):650-660.
-
Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease. J Am Heart Assoc. 2025 09 16; 14(18):e040058.
-
Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 06; 81(6):1467-1478.e1.
-
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy. Cardiovasc Diabetol. 2024 12 20; 23(1):450.
-
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2024 11 15; 210(10):1210-1218.
-
The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
-
How to interpret a cardiorespiratory fitness assessment - Key measures that provide the best picture of health, disease status and prognosis. Prog Cardiovasc Dis. 2024 Mar-Apr; 83:23-28.
-
Isosorbide DiNitrate Effect on Hemodynamic Profile, Liver Stiffness, and Exercise Tolerance in Fontan Circulation (The NEET Clinical Trial). Pediatr Cardiol. 2024 Oct; 45(7):1389-1397.
-
Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.